• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

290
73
51
51
34

COUNTRY

33
13
13
12
12

PRICE

711
891
1,108
1,672

PUBLISHED

9
77
321
1,672

PRODUCT TYPE

1,072
499
83
16
2

Infectious Diseases

Antibiotics, antifungals, antivirals and other infectious disease pharmaceuticals account for a multibillion sector. The battle against contagious diseases takes places in a highly changeable environment, with a wealth of commercial opportunities arising from quickly emerging threats (e.g. avian flu) and the infectious disease and vaccination policies of national governments and international healthcare organisations. Keep track of the latest industry news and activity with the publications listed under Research and Markets’ Infectious Diseases category.

Our reports, books, and subscriptions will allow you to explore licensing, patents, forecasts, market trends, clinical trials, and drug pipelines. Leading players featured in our publications include Pfizer, Roche, Novartis, AstraZeneca, Sanofi, Johnson & Johnson, Merck, Abbott, GlaxoSmithKline, Lilly, and more.

For publications about Infectious Disease Testing please visit the relevant category under Healthcare and Medical Devices. Show Less
Read more

PRODUCT TITLE

Cholera - Pipeline Review, H2 2013

Cholera - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Cholera - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

September 2013
FROM

Bacterial Pneumonia - Pipeline Review, H2 2013

Bacterial Pneumonia - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Bacterial Pneumonia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

September 2013
FROM

H1N1 Infection - Pipeline Review, H2 2013

H1N1 Infection - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'H1N1 Infection - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

September 2013
FROM

Complicated Intra-Abdominal Infections - Pipeline Review, H2 2013

Complicated Intra-Abdominal Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Complicated Intra-Abdominal Infections - Pipeline Review, H2 2013', provides an overview of the...

September 2013
FROM

Dengue - Pipeline Review, H2 2013

Dengue - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Dengue - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

September 2013
FROM

Tetanus - Pipeline Review, H2 2013

Tetanus - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Tetanus - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

September 2013
FROM

Meningococcemia (Meningococcal Infections) - Pipeline Review, H2 2013

Meningococcemia (Meningococcal Infections) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Meningococcemia (Meningococcal Infections) - Pipeline Review, H2 2013', provides an overview...

September 2013
FROM

Typhoid Fever - Pipeline Review, H2 2013

Typhoid Fever - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Typhoid Fever - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

September 2013
FROM

Nosocomial Infections - Pipeline Review, H2 2013

Nosocomial Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Nosocomial Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

September 2013
FROM

Polio - Pipeline Review, H2 2013

Polio - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Polio - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

September 2013
FROM

Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2013

Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

September 2013
FROM

Herpes Simplex Infections - Pipeline Review, H2 2013

Herpes Simplex Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Herpes Simplex Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

September 2013
FROM

Smallpox - Pipeline Review, H2 2013

Smallpox - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Smallpox - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

September 2013
FROM

Klebsiella Pneumoniae Infections - Pipeline Review, H2 2013

Klebsiella Pneumoniae Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Klebsiella Pneumoniae Infections - Pipeline Review, H2 2013', provides an overview of the indication’s...

September 2013
FROM

Malaria - Pipeline Review, H2 2013

Malaria - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Malaria - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

September 2013
FROM

Pertussis - Pipeline Review, H2 2013

Pertussis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Pertussis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

September 2013
FROM

Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2013

Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

September 2013
FROM

African Trypanosomiasis - Pipeline Review, H2 2013

African Trypanosomiasis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'African Trypanosomiasis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

September 2013
FROM

Candidiasis - Pipeline Review, H2 2013

Candidiasis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Candidiasis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

September 2013
FROM
2014 Opportunities in the Japanese Infectious Disease Testing Market (Datapack) 2014 Opportunities in the Japanese Infectious Disease Testing Market (Datapack) - Product Thumbnail Image

2014 Opportunities in the Japanese Infectious Disease Testing Market (Datapack)

2014 Opportunities in the Japanese Infectious Disease Testing Market is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five...

September 2013
Loading Indicator

Our Clients

Our clients' logos